Hormone Replacement Therapy Market

Hormone Replacement Therapy Market Size by Product Type (Growth Hormone Replacement, Testosterone Hormone Replacement, Progesterone & Estrogen Replacement Theory, Parathyroid Hormone Replacement and Human Growth Hormone Replacement Theory), Administration Route (Parenteral, Oral and Transdermal), Indication (Hypothyroidism, Menopause, Growth Hormone Deficiency and Male Hypogonadism), Distribution Channel (Retail Pharmacy, Hospital Pharmacy and Online Pharmacy), Regions, Global Industry Analysis, Share, Growth, Trends, and Forecast 2023 to 2032

Base Year: 2022 Historical Data: 2019-21
  • Report ID: TBI-12564
  • Published Date: Oct, 2023
  • Pages: 236
  • Category: Healthcare
  • Format: PDF
Buy @ $4700.00 Request Sample PDF

The global hormone replacement therapy market was valued at USD 20.48 Billion in 2022 and grew at a CAGR of 7.17% from 2023 to 2032. The market is expected to reach USD 40.93 Billion by 2032. The demand for controlling the symptoms of menopause and hyperthyroidism, as well as many hormone-related disorders, is driving an increase in the use of hormone replacement therapy.

Market Introduction:

Female hormones are present in medications used for hormone replacement therapy. In postmenopausal women, hormone therapy has also been shown to minimize fractures and stop bone loss. Menopause symptoms can be treated with hormone replacement therapy. Some women only experience moderate symptoms, which resolve on their own. Many women turn to hormone replacement treatment to alleviate these symptoms, known as menopausal hormone therapy. The main goal of hormone replacement treatment is to replenish the oestrogen that the body no longer produces after menopause. To avoid symptoms like hot flashes and night sweats during menopause, hormone replacement treatment can help balance oestrogen and progesterone levels. The primary hormone replacement therapy subtypes are based on naturally occurring hormones, including progesterone, oestrogen, and testosterone.

Hormone Replacement Therapy Market Size

Get an overview of this study by requesting a free sample

Recent Development
  • In November 2021, a significant player, I-MAB Biopharma Co., Ltd., had agreed on an agreement with Jumpcan Pharmaceutical Group for the marketing and development of eftansomatropin alfa, named TJ101 in China, I-MAB Biopharma Co., Ltd. has partnered with Jumpcan Pharmaceutical Group. TJ101 is a long-acting recombinant human growth hormone intended to treat paediatric growth hormone insufficiency.

Market Dynamics:

Drivers

Growing uses of hormone replacement theory: Oestrogen, progesterone, and occasionally testosterone are present in hormone replacement theory. When menopause symptoms interfere with their daily life, it is utilized to treat them. The main advantage of hormone replacement theory is that it effectively treats most perimenopause and menopause symptoms, including vaginal dryness, flushes, night sweats, and sleep issues brought on by menopause. Most women between the ages of 35 and 55 participated in the trials that revealed hormone therapy reduced the risk of heart attack. As they approached menopause or when they first started to feel uneasy, they began taking the drug. Hormone replacement theory successfully treats menopausal symptoms in the early postmenopausal years.

Restraints:

Side-effects: Osteoporosis, or bone thinning, can be brought on by specific hormone therapy. As a result, bones become more brittle and, in some situations, more prone to breaking or fracture. The risk for various health issues rises with several hormone therapies. They may include cataracts, heart attacks, strokes, and blood clots. They may also raise the chance of developing uterine cancer.

Opportunities:

Rising incidence of hyperthyroidism: Thyrotoxicosis can result from the thyroid gland secreting excessive thyroid hormone levels, a disease known as hyperthyroidism. In the U.S., hyperthyroidism affects roughly 1.2% of the population. There are numerous causes of hyperthyroidism, but the most frequent ones are toxic multinodular goitre, toxic adenoma, and Graves disease. Clinical findings can be used to diagnose, which can then be verified by biochemical tests, imaging methods such as ultrasonography, and radioactive iodine uptake studies. Graves' disease is the root cause of 60–80% of thyrotoxicosis cases in the United States. According to reports, there are 50 occurrences of Graves' illness for every 100,000 persons, with the highest incidence occurring in people between the ages of 20 and 40.

Regional segmentation analysis:

The regions analyzed for the market include North America, Europe, South America, Asia Pacific, the Middle East, and Africa. North America emerged as the most significant Hormone Replacement Therapy market, with a 42.81% market revenue share in 2022.

North America region will account for the largest market share with revenue growth. Nations such as the U.S., Canada and Mexico have a tremendous demand for hormone replacement therapy due to the increasing geriatric population, rising incidence of pre-menopause cases and hormone deficiency disorders. Major product releases, manufacturer collaboration agreements, and favourable reimbursement policies promote the use of the region's significant market share of hormone replacement therapy.

North America region Hormone Replacement Therapy Market Share in 2022 - 42.81%

 

www.thebrainyinsights.com

Check the geographical analysis of this market by requesting a free sample

Product Type Segment Analysis

The product type segment is divided into growth hormone replacement, testosterone hormone replacement, progesterone & estrogen replacement theory, parathyroid hormone replacement and human growth hormone replacement theory. The progesterone & estrogen replacement theory segment dominated the market, with a share of around 49.32% in 2022. The two hormones most commonly utilized in HRT are oestrogens and progestogens. The primary female hormone, progesterone, is produced artificially as a medication for menopausal hormone treatment. Progestogen is explicitly added to oestrogen regimens unless the uterus has been removed to reduce the chance of endometrial cancer, even though both classes of hormones can help with symptoms.

Administration Route Segment Analysis

The administration route segment is divided into parenteral, oral and transdermal. The oral segment dominated the market, with a share of around 49.19% in 2022. The most popular ERT treatment method is oral medicine. There are many formulated tablets available that can be used as hormone replacement therapy. Typically, the oral medication is prescribed once per day. Further, oral medication does not cause any pain; thus, it is mostly preferred by the patients.

Indication Segment Analysis

The indication segment is divided into hypothyroidism, menopause, growth hormone deficiency and male hypogonadism. The menopause segment dominated the market, with a share of around 48.03% in 2022. Hormone treatment replaces a woman's declining hormone levels with synthetic oestrogen and progestogen to lessen menopausal symptoms. One of the medications the government has licenced for treating menopausal symptoms is hormone therapy. Low oestrogen levels bring on these symptoms, and hormone replacement theory boosts the oestrogen, relieving the woman.

Distribution Channel Segment Analysis

The distribution channel segment is divided into retail pharmacy, hospital pharmacy and online pharmacy. The hospital pharmacy segment dominated the market, with a share of around 56.21% in 2022. An integral aspect of patient care in a healthcare facility, hospital pharmacy is a specialized area of pharmacy. Hormone replacement therapy drugs are mostly available at hospital pharmacies, and the patient can buy them only with a doctor's prescription.

Some of the Key Market Players:
  • Eli Lilly and Company
  • Noven Pharmaceuticals, Inc.
  • Bayer AG, Pfizer Inc.
  • Viatris, Inc
  • Merck & Co., Inc.
  • Novo Nordisk A/S
  • ASCEND Therapeutics U.S., LLC.
  • F. Hoffmann-La Roche Ltd.
  • AbbVie, Inc.
  • Abbott Laboratories
  • Mylan N.V.
  • Novartis International AG

Report Description: 

Attribute Description
Market Size Revenue (USD Billion)
Market size value in 2022 USD 20.48 Billion
Market size value in 2032 USD 40.93 Billion
CAGR (2023 to 2032) 7.17%
Historical data 2019-2021
Base Year 2022
Forecast 2023-2032
Region The regions analyzed for the market are Asia Pacific, Europe, South America, North America, and Middle East & Africa. Furthermore, the regions are further analyzed at the country level.
Segments Product Type, Administration Route, Indication and Distribution Channel

Frequesntly Asked Questions

As per The Brainy Insights, the size of the hormone replacement therapy market was valued USD 20.48 billion in 2022 to USD 40.93 billion by 2032.

Global hormone replacement therapy market is growing at a CAGR of 7.17% during the forecast period 2023-2032.

North America region emerged as the largest market for the hormone replacement therapy.

The market's growth will be influenced by the rising usage of hormone replacement therapy.

The potential side-effects can hamper the market growth.

The rising incidence of hyperthyroidism and hormone related disorders is providing lucrative opportunities to the market.

Key players are Eli Lilly and Company, Noven Pharmaceuticals, Inc., Bayer AG, Pfizer Inc., Viatris, Inc., Merck & Co., Inc., Novo Nordisk A/S, ASCEND Therapeutics US, LLC., F. Hoffmann-La Roche Ltd., AbbVie

1. Introduction
    1.1. Objectives of the Study
    1.2. Market Definition
    1.3. Research Scope
    1.4. Currency
    1.5. Key Target Audience

2. Research Methodology and Assumptions

3. Executive Summary

4. Premium Insights
    4.1. Porter’s Five Forces Analysis
    4.2. Value Chain Analysis
    4.3. Top Investment Pockets
          4.3.1. Market Attractiveness Analysis by Product Type
          4.3.2. Market Attractiveness Analysis by Administration Route
          4.3.3. Market Attractiveness Analysis by Indication
          4.3.4. Market Attractiveness Analysis by Distribution Channel
          4.3.5. Market Attractiveness Analysis by Region
    4.4. Industry Trends

5. Market Dynamics
    5.1. Market Evaluation
    5.2. Drivers
          5.2.1. Increasing usage of hormone replacement therapy
    5.3. Restraints
          5.3.1. Potential side-effects
    5.4. Opportunities
          5.4.1. Increasing incidence of hyperthyroidism
    5.5. Challenges
          5.5.1. Supply chain disruptions

6. Global Hormone Replacement Therapy Market Analysis and Forecast, By Product Type
    6.1. Segment Overview
    6.2. Growth Hormone Replacement
    6.3. Testosterone Hormone Replacement
    6.4. Progesterone & Estrogen Replacement Theory
    6.5. Parathyroid Hormone Replacement
    6.6. Human Growth Hormone Replacement Theory

7. Global Hormone Replacement Therapy Market Analysis and Forecast, By Administration Route
    7.1. Segment Overview
    7.2. Parenteral
    7.3. Oral
    7.4. Transdermal

8. Global Hormone Replacement Therapy Market Analysis and Forecast, By Indication
    8.1. Segment Overview
    8.2. Hypothyroidism
    8.3. Menopause
    8.4. Growth Hormone Deficiency
    8.5. Male Hypogonadism

9. Global Hormone Replacement Therapy Market Analysis and Forecast, By Distribution Channel
    9.1. Segment Overview
    9.2. Retail Pharmacy
    9.3. Hospital Pharmacy
    9.4. Online Pharmacy

10. Global Hormone Replacement Therapy Market Analysis and Forecast, By Regional Analysis
    10.1. Segment Overview
    10.2. North America
          10.2.1. U.S.
          10.2.2. Canada
          10.2.3. Mexico
    10.3. Europe
          10.3.1. Germany
          10.3.2. France
          10.3.3. U.K.
          10.3.4. Italy
          10.3.5. Spain
    10.4. Asia-Pacific
          10.4.1. Japan
          10.4.2. China
          10.4.3. India
    10.5. South America
          10.5.1. Brazil
    10.6. Middle East and Africa
          10.6.1. UAE
          10.6.2. South Africa

11. Global Hormone Replacement Therapy Market-Competitive Landscape
    11.1. Overview
    11.2. Market Share of Key Players in the Hormone Replacement Therapy Market
          11.2.1. Global Company Market Share
          11.2.2. North America Company Market Share
          11.2.3. Europe Company Market Share
          11.2.4. APAC Company Market Share
    11.3. Competitive Situations and Trends
          11.3.1. Product Launches and Developments
          11.3.2. Partnerships, Collaborations, and Agreements
          11.3.3. Mergers & Acquisitions
          11.3.4. Expansions

12. Company Profiles
    12.1. Eli Lilly and Company
          12.1.1. Business Overview
          12.1.2. Company Snapshot
          12.1.3. Company Market Share Analysis
          12.1.4. Company Product Portfolio
          12.1.5. Recent Developments
          12.1.6. SWOT Analysis
    12.2. Noven Pharmaceuticals, Inc.
          12.2.1. Business Overview
          12.2.2. Company Snapshot
          12.2.3. Company Market Share Analysis
          12.2.4. Company Product Portfolio
          12.2.5. Recent Developments
          12.2.6. SWOT Analysis
    12.3. Bayer AG
          12.3.1. Business Overview
          12.3.2. Company Snapshot
          12.3.3. Company Market Share Analysis
          12.3.4. Company Product Portfolio
          12.3.5. Recent Developments
          12.3.6. SWOT Analysis
    12.4. Pfizer Inc.
          12.4.1. Business Overview
          12.4.2. Company Snapshot
          12.4.3. Company Market Share Analysis
          12.4.4. Company Product Portfolio
          12.4.5. Recent Developments
          12.4.6. SWOT Analysis
    12.5. Viatris, Inc
          12.5.1. Business Overview
          12.5.2. Company Snapshot
          12.5.3. Company Market Share Analysis
          12.5.4. Company Product Portfolio
          12.5.5. Recent Developments
          12.5.6. SWOT Analysis
    12.6. Merck & Co., Inc.
          12.6.1. Business Overview
          12.6.2. Company Snapshot
          12.6.3. Company Market Share Analysis
          12.6.4. Company Product Portfolio
          12.6.5. Recent Developments
          12.6.6. SWOT Analysis
    12.7. Novo Nordisk A/S
          12.7.1. Business Overview
          12.7.2. Company Snapshot
          12.7.3. Company Market Share Analysis
          12.7.4. Company Product Portfolio
          12.7.5. Recent Developments
          12.7.6. SWOT Analysis
    12.8. ASCEND Therapeutics US, LLC.
          12.8.1. Business Overview
          12.8.2. Company Snapshot
          12.8.3. Company Market Share Analysis
          12.8.4. Company Product Portfolio
          12.8.5. Recent Developments
          12.8.6. SWOT Analysis
    12.9. F. Hoffmann-La Roche Ltd.
          12.9.1. Business Overview
          12.9.2. Company Snapshot
          12.9.3. Company Market Share Analysis
          12.9.4. Company Product Portfolio
          12.9.5. Recent Developments
          12.9.6. SWOT Analysis
    12.10. AbbVie, Inc
          12.10.1. Business Overview
          12.10.2. Company Snapshot
          12.10.3. Company Market Share Analysis
          12.10.4. Company Product Portfolio
          12.10.5. Recent Developments
          12.10.6. SWOT Analysis
    12.11. Abbott Laboratories
          12.11.1. Business Overview
          12.11.2. Company Snapshot
          12.11.3. Company Market Share Analysis
          12.11.4. Company Product Portfolio
          12.11.5. Recent Developments
          12.11.6. SWOT Analysis
    12.12. Mylan N.V.
          12.12.1. Business Overview
          12.12.2. Company Snapshot
          12.12.3. Company Market Share Analysis
          12.12.4. Company Product Portfolio
          12.12.5. Recent Developments
          12.12.6. SWOT Analysis
    12.13. Novartis International AG
          12.13.1. Business Overview
          12.13.2. Company Snapshot
          12.13.3. Company Market Share Analysis
          12.13.4. Company Product Portfolio
          12.13.5. Recent Developments
          12.13.6. SWOT Analysis
 

List of Table

1. Global Hormone Replacement Therapy Market, By Product Type, 2019-2032 (USD Billion) 

2. Global Growth Hormone Replacement, Hormone Replacement Therapy Market, By Region, 2019-2032 (USD Billion) 

3. Global Testosterone Hormone Replacement, Hormone Replacement Therapy Market, By Region, 2019-2032 (USD Billion) 

4. Global Progesterone & Estrogen Replacement Theory, Hormone Replacement Therapy Market, By Region, 2019-2032 (USD Billion) 

5. Global Parathyroid Hormone Replacement, Hormone Replacement Therapy Market, By Region, 2019-2032 (USD Billion) 

6. Global Human Growth Hormone Replacement Theory, Hormone Replacement Therapy Market, By Region, 2019-2032 (USD Billion) 

7. Global Hormone Replacement Therapy Market, By Administration Route, 2019-2032 (USD Billion) 

8. Global Parenteral, Hormone Replacement Therapy Market, By Region, 2019-2032 (USD Billion) 

9. Global Oral, Hormone Replacement Therapy Market, By Region, 2019-2032 (USD Billion) 

10. Global Transdermal, Hormone Replacement Therapy Market, By Region, 2019-2032 (USD Billion) 

11. Global Hormone Replacement Therapy Market, By Indication, 2019-2032 (USD Billion) 

12. Global Hypothyroidism, Hormone Replacement Therapy Market, By Region, 2019-2032 (USD Billion) 

13. Global Menopause, Hormone Replacement Therapy Market, By Region, 2019-2032 (USD Billion) 

14. Global Growth Hormone Deficiency, Hormone Replacement Therapy Market, By Region, 2019-2032 (USD Billion) 

15. Global Male Hypogonadism, Hormone Replacement Therapy Market, By Region, 2019-2032 (USD Billion) 

16. Global Hormone Replacement Therapy Market, By Distribution Channel, 2019-2032 (USD Billion) 

17. Global Retail Pharmacy, Hormone Replacement Therapy Market, By Region, 2019-2032 (USD Billion) 

18. Global Hospital Pharmacy, Hormone Replacement Therapy Market, By Region, 2019-2032 (USD Billion) 

19. Global Online Pharmacy, Hormone Replacement Therapy Market, By Region, 2019-2032 (USD Billion)  

20. Global Hormone Replacement Therapy Market, By Region, 2019-2032 (USD Billion) 

21. North America Hormone Replacement Therapy Market, By Product Type, 2019-2032 (USD Billion) 

22. North America Hormone Replacement Therapy Market, By Administration Route, 2019-2032 (USD Billion) 

23. North America Hormone Replacement Therapy Market, By Indication, 2019-2032 (USD Billion)

24. North America Hormone Replacement Therapy Market, By Distribution Channel, 2019-2032 (USD Billion) 

25. U.S. Hormone Replacement Therapy Market, By Product Type, 2019-2032 (USD Billion) 

26. U.S. Hormone Replacement Therapy Market, By Administration Route, 2019-2032 (USD Billion) 

27. U.S. Hormone Replacement Therapy Market, By Indication, 2019-2032 (USD Billion) 

28. U.S. Hormone Replacement Therapy Market, By Distribution Channel, 2019-2032 (USD Billion) 

29. Canada Hormone Replacement Therapy Market, By Product Type, 2019-2032 (USD Billion) 

30. Canada Hormone Replacement Therapy Market, By Administration Route, 2019-2032 (USD Billion) 

31. Canada Hormone Replacement Therapy Market, By Indication, 2019-2032 (USD Billion) 

32. Canada Hormone Replacement Therapy Market, By Distribution Channel, 2019-2032 (USD Billion) 

33. Mexico Hormone Replacement Therapy Market, By Product Type, 2019-2032 (USD Billion) 

34. Mexico Hormone Replacement Therapy Market, By Administration Route, 2019-2032 (USD Billion) 

35. Mexico Hormone Replacement Therapy Market, By Indication, 2019-2032 (USD Billion) 

36. Mexico Hormone Replacement Therapy Market, By Distribution Channel, 2019-2032 (USD Billion) 

37. Europe Hormone Replacement Therapy Market, By Product Type, 2019-2032 (USD Billion) 

38. Europe Hormone Replacement Therapy Market, By Administration Route, 2019-2032 (USD Billion) 

39. Europe Hormone Replacement Therapy Market, By Indication, 2019-2032 (USD Billion)

40. Europe Hormone Replacement Therapy Market, By Distribution Channel, 2019-2032 (USD Billion) 

41. Germany Hormone Replacement Therapy Market, By Product Type, 2019-2032 (USD Billion) 

42. Germany Hormone Replacement Therapy Market, By Administration Route, 2019-2032 (USD Billion) 

43. Germany Hormone Replacement Therapy Market, By Indication, 2019-2032 (USD Billion) 

44. Germany Hormone Replacement Therapy Market, By Distribution Channel, 2019-2032 (USD Billion) 

45. France Hormone Replacement Therapy Market, By Product Type, 2019-2032 (USD Billion) 

46. France Hormone Replacement Therapy Market, By Administration Route, 2019-2032 (USD Billion) 

47. France Hormone Replacement Therapy Market, By Indication, 2019-2032 (USD Billion) 

48. France Hormone Replacement Therapy Market, By Distribution Channel, 2019-2032 (USD Billion) 

49. U.K. Hormone Replacement Therapy Market, By Product Type, 2019-2032 (USD Billion) 

50. U.K. Hormone Replacement Therapy Market, By Administration Route, 2019-2032 (USD Billion) 

51. U.K. Hormone Replacement Therapy Market, By Indication, 2019-2032 (USD Billion) 

52. U.K. Hormone Replacement Therapy Market, By Distribution Channel, 2019-2032 (USD Billion) 

53. Italy Hormone Replacement Therapy Market, By Product Type, 2019-2032 (USD Billion) 

54. Italy Hormone Replacement Therapy Market, By Administration Route, 2019-2032 (USD Billion) 

55. Italy Hormone Replacement Therapy Market, By Indication, 2019-2032 (USD Billion) 

56. Italy Hormone Replacement Therapy Market, By Distribution Channel, 2019-2032 (USD Billion) 

57. Spain Hormone Replacement Therapy Market, By Product Type, 2019-2032 (USD Billion) 

58. Spain Hormone Replacement Therapy Market, By Administration Route, 2019-2032 (USD Billion) 

59. Spain Hormone Replacement Therapy Market, By Indication, 2019-2032 (USD Billion) 

60. Spain Hormone Replacement Therapy Market, By Distribution Channel, 2019-2032 (USD Billion) 

61. Asia Pacific Hormone Replacement Therapy Market, By Product Type, 2019-2032 (USD Billion) 

62. Asia Pacific Hormone Replacement Therapy Market, By Administration Route, 2019-2032 (USD Billion) 

63. Asia Pacific Hormone Replacement Therapy Market, By Indication, 2019-2032 (USD Billion) 

64. Asia Pacific Hormone Replacement Therapy Market, By Distribution Channel, 2019-2032 (USD Billion) 

65. Japan Hormone Replacement Therapy Market, By Product Type, 2019-2032 (USD Billion) 

66. Japan Hormone Replacement Therapy Market, By Administration Route, 2019-2032 (USD Billion) 

67. Japan Hormone Replacement Therapy Market, By Indication, 2019-2032 (USD Billion)

68. Japan Hormone Replacement Therapy Market, By Distribution Channel, 2019-2032 (USD Billion) 

69. China Hormone Replacement Therapy Market, By Product Type, 2019-2032 (USD Billion) 

70. China Hormone Replacement Therapy Market, By Administration Route, 2019-2032 (USD Billion) 

71. China Hormone Replacement Therapy Market, By Indication, 2019-2032 (USD Billion) 

72. China Hormone Replacement Therapy Market, By Distribution Channel, 2019-2032 (USD Billion) 

73. India Hormone Replacement Therapy Market, By Product Type, 2019-2032 (USD Billion) 

74. India Hormone Replacement Therapy Market, By Administration Route, 2019-2032 (USD Billion) 

75. India Hormone Replacement Therapy Market, By Indication, 2019-2032 (USD Billion) 

76. India Hormone Replacement Therapy Market, By Distribution Channel, 2019-2032 (USD Billion) 

77. South America Hormone Replacement Therapy Market, By Product Type, 2019-2032 (USD Billion) 

78. South America Hormone Replacement Therapy Market, By Administration Route, 2019-2032 (USD Billion) 

79. South America Hormone Replacement Therapy Market, By Indication, 2019-2032 (USD Billion) 

80. South America Hormone Replacement Therapy Market, By Distribution Channel, 2019-2032 (USD Billion) 

81. Brazil Hormone Replacement Therapy Market, By Product Type, 2019-2032 (USD Billion) 

82. Brazil Hormone Replacement Therapy Market, By Administration Route, 2019-2032 (USD Billion) 

83. Brazil Hormone Replacement Therapy Market, By Indication, 2019-2032 (USD Billion) 

84. BrazilHormone Replacement Therapy Market, By Distribution Channel, 2019-2032 (USD Billion) 

85. Middle East and Africa Hormone Replacement Therapy Market, By Product Type, 2019-2032 (USD Billion) 

86. Middle East and Africa Hormone Replacement Therapy Market, By Administration Route, 2019-2032 (USD Billion) 

87. Middle East and Africa Hormone Replacement Therapy Market, By Indication, 2019-2032 (USD Billion) 

88. Middle East and Africa Hormone Replacement Therapy Market, By Distribution Channel, 2019-2032 (USD Billion) 

89. UAE Hormone Replacement Therapy Market, By Product Type, 2019-2032 (USD Billion) 

90. UAE Hormone Replacement Therapy Market, By Administration Route, 2019-2032 (USD Billion) 

91. UAE Hormone Replacement Therapy Market, By Indication, 2019-2032 (USD Billion) 

92. UAE Hormone Replacement Therapy Market, By Distribution Channel, 2019-2032 (USD Billion) 

93. South Africa Hormone Replacement Therapy Market, By Product Type, 2019-2032 (USD Billion) 

94. South Africa Hormone Replacement Therapy Market, By Administration Route, 2019-2032 (USD Billion) 

95. South Africa Hormone Replacement Therapy Market, By Indication, 2019-2032 (USD Billion) 

96. South Africa Hormone Replacement Therapy Market, By Distribution Channel, 2019-2032 (USD Billion)  

List of Figures

1. Global Hormone Replacement Therapy Market Segmentation

2. Hormone Replacement Therapy Market: Research Methodology

3. Market Size Estimation Methodology: Bottom-Up Approach

4. Market Size Estimation Methodology: Top-Down Approach

5. Data Triangulation

6. Porter’s Five Forces Analysis 

7. Value Chain Analysis 

8. Global Hormone Replacement Therapy Market Attractiveness Analysis by Product Type

9. Global Hormone Replacement Therapy Market Attractiveness Analysis by Administration Route

10. Global Hormone Replacement Therapy Market Attractiveness Analysis by Indication

11. Global Hormone Replacement Therapy Market Attractiveness Analysis by Distribution Channel

12. Global Hormone Replacement Therapy Market Attractiveness Analysis by Region

13. Global Hormone Replacement Therapy Market: Dynamics

14. Global Hormone Replacement Therapy Market Share by Product Type (2022 & 2032)

15. Global Hormone Replacement Therapy Market Share by Administration Route (2022 & 2032)

16. Global Hormone Replacement Therapy Market Share by Indication (2022 & 2032)

17. Global Hormone Replacement Therapy Market Share by Distribution Channel (2022 & 2032)

18. Global Hormone Replacement Therapy Market Share by Regions (2022 & 2032)

19. Global Hormone Replacement Therapy Market Share by Company (2022)

This study forecasts revenue at global, regional, and country levels from 2019 to 2032. The Brainy Insights has segmented the global hormone replacement therapy market based on below mentioned segments:

Global Hormone Replacement Therapy Market by Product Type:

  • Growth Hormone Replacement
  • Testosterone Hormone Replacement
  • Progesterone & Estrogen Replacement Theory
  • Parathyroid Hormone Replacement
  • Human Growth Hormone Replacement Theory

Global Hormone Replacement Therapy Market by Administration Route:

  • Parenteral
  • Oral
  • Transdermal

Global Hormone Replacement Therapy Market by Indication:

  • Hypothyroidism
  • Menopause
  • Growth Hormone Deficiency
  • Male Hypogonadism

Global Hormone Replacement Therapy Market by Distribution Channel:

  • Retail Pharmacy
  • Hospital Pharmacy
  • Online Pharmacy

Global Hormone Replacement Therapy Market by Region:

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
  • Asia-Pacific
    • Japan
    • China
    • India
  • South America
    • Brazil
  • Middle East and Africa  
    • UAE
    • South Africa

Methodology

Research has its special purpose to undertake marketing efficiently. In this competitive scenario, businesses need information across all industry verticals; the information about customer wants, market demand, competition, industry trends, distribution channels etc. This information needs to be updated regularly because businesses operate in a dynamic environment. Our organization, The Brainy Insights incorporates scientific and systematic research procedures in order to get proper market insights and industry analysis for overall business success. The analysis consists of studying the market from a miniscule level wherein we implement statistical tools which helps us in examining the data with accuracy and precision. 

Our research reports feature both; quantitative and qualitative aspects for any market. Qualitative information for any market research process are fundamental because they reveal the customer needs and wants, usage and consumption for any product/service related to a specific industry. This in turn aids the marketers/investors in knowing certain perceptions of the customers. Qualitative research can enlighten about the different product concepts and designs along with unique service offering that in turn, helps define marketing problems and generate opportunities. On the other hand, quantitative research engages with the data collection process through interviews, e-mail interactions, surveys and pilot studies. Quantitative aspects for the market research are useful to validate the hypotheses generated during qualitative research method, explore empirical patterns in the data with the help of statistical tools, and finally make the market estimations.

The Brainy Insights offers comprehensive research and analysis, based on a wide assortment of factual insights gained through interviews with CXOs and global experts and secondary data from reliable sources. Our analysts and industry specialist assume vital roles in building up statistical tools and analysis models, which are used to analyse the data and arrive at accurate insights with exceedingly informative research discoveries. The data provided by our organization have proven precious to a diverse range of companies, facilitating them to address issues such as determining which products/services are the most appealing, whether or not customers use the product in the manner anticipated, the purchasing intentions of the market and many others.

Our research methodology encompasses an idyllic combination of primary and secondary initiatives. Key phases involved in this process are listed below:

MARKET RESEARCH PROCESS

Data Procurement:

The phase involves the gathering and collecting of market data and its related information with the help of different sources & research procedures.

The data procurement stage involves in data gathering and collecting through various data sources.

This stage involves in extensive research. These data sources includes:

Purchased Database: Purchased databases play a crucial role in estimating the market sizes irrespective of the domain. Our purchased database includes:

  • The organizational databases such as D&B Hoovers, and Bloomberg that helps us to identify the competitive scenario of the key market players/organizations along with the financial information.
  • Industry/Market databases such as Statista, and Factiva provides market/industry insights and deduce certain formulations. 
  • We also have contractual agreements with various reputed data providers and third party vendors who provide information which are not limited to:
    • Import & Export Data
    • Business Trade Information
    • Usage rates of a particular product/service on certain demographics mainly focusing on the unmet prerequisites

Primary Research: The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. Primary research mainly involves in telephonic interviews, E-mail interactions and face-to-face interviews with the raw material providers, manufacturers/producers, distributors, & independent consultants. The interviews that we conduct provides valuable data on market size and industry growth trends prevailing in the market. Our organization also conducts surveys with the various industry experts in order to gain overall insights of the industry/market. For instance, in healthcare industry we conduct surveys with the pharmacists, doctors, surgeons and nurses in order to gain insights and key information of a medical product/device/equipment which the customers are going to usage. Surveys are conducted in the form of questionnaire designed by our own analyst team. Surveys plays an important role in primary research because surveys helps us to identify the key target audiences of the market. Additionally, surveys helps to identify the key target audience engaged with the market. Our survey team conducts the survey by targeting the key audience, thus gaining insights from them. Based on the perspectives of the customers, this information is utilized to formulate market strategies. Moreover, market surveys helps us to understand the current competitive situation of the industry. To be precise, our survey process typically involve with the 360 analysis of the market. This analytical process begins by identifying the prospective customers for a product or service related to the market/industry to obtain data on how a product/service could fit into customers’ lives.

Secondary Research: The secondary data sources includes information published by the on-profit organizations such as World bank, WHO, company fillings, investor presentations, annual reports, national government documents, statistical databases, blogs, articles, white papers and others. From the annual report, we analyse a company’s revenue to understand the key segment and market share of that organization in a particular region. We analyse the company websites and adopt the product mapping technique which is important for deriving the segment revenue. In the product mapping method, we select and categorize the products offered by the companies catering to domain specific market, deduce the product revenue for each of the companies so as to get overall estimation of the market size. We also source data and analyses trends based on information received from supply side and demand side intermediaries in the value chain. The supply side denotes the data gathered from supplier, distributor, wholesaler and the demand side illustrates the data gathered from the end customers for respective market domain.

The supply side for a domain specific market is analysed by:

  • Estimating and projecting penetration rates through analysing product attributes, availability of internal and external substitutes, followed by pricing analysis of the product.
  • Experiential assessment of year-on-year sales of the product by conducting interviews.

The demand side for the market is estimated through:

  • Evaluating the penetration level and usage rates of the product.
  • Referring to the historical data to determine the growth rate and evaluate the industry trends

In-house Library: Apart from these third-party sources, we have our in-house library of qualitative and quantitative information. Our in-house database includes market data for various industry and domains. These data are updated on regular basis as per the changing market scenario. Our library includes, historic databases, internal audit reports and archives.

Sometimes there are instances where there is no metadata or raw data available for any domain specific market. For those cases, we use our expertise to forecast and estimate the market size in order to generate comprehensive data sets. Our analyst team adopt a robust research technique in order to produce the estimates:

  • Applying demographic along with psychographic segmentation for market evaluation
  • Determining the Micro and Macro-economic indicators for each region 
  • Examining the industry indicators prevailing in the market. 

Data Synthesis: This stage involves the analysis & mapping of all the information obtained from the previous step. It also involves in scrutinizing the data for any discrepancy observed while data gathering related to the market. The data is collected with consideration to the heterogeneity of sources. Robust scientific techniques are in place for synthesizing disparate data sets and provide the essential contextual information that can orient market strategies. The Brainy Insights has extensive experience in data synthesis where the data passes through various stages:

  • Data Screening: Data screening is the process of scrutinising data/information collected from primary research for errors and amending those collected data before data integration method. The screening involves in examining raw data, identifying errors and dealing with missing data. The purpose of the data screening is to ensure data is correctly entered or not. The Brainy Insights employs objective and systematic data screening grades involving repeated cycles of quality checks, screening and suspect analysis.
  • Data Integration: Integrating multiple data streams is necessary to produce research studies that provide in-depth picture to the clients. These data streams come from multiple research studies and our in house database. After screening of the data, our analysts conduct creative integration of data sets, optimizing connections between integrated surveys and syndicated data sources. There are mainly 2 research approaches that we follow in order to integrate our data; top down approach and bottom up approach.

Market Deduction & Formulation: The final stage comprises of assigning data points at appropriate market spaces so as to deduce feasible conclusions. Analyst perspective & subject matter expert based holistic form of market sizing coupled with industry analysis also plays a crucial role in this stage.

This stage involves in finalization of the market size and numbers that we have collected from data integration step. With data interpolation, it is made sure that there is no gap in the market data. Successful trend analysis is done by our analysts using extrapolation techniques, which provide the best possible forecasts for the market.

Data Validation & Market Feedback: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helps us finalize data-points to be used for final calculations.

The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. The data validation interview and discussion panels are typically composed of the most experienced industry members. The participants include, however, are not limited to:

  • CXOs and VPs of leading companies’ specific to sector
  • Purchasing managers, technical personnel, end-users
  • Key opinion leaders such as investment bankers, and industry consultants

Moreover, we always validate our data and findings through primary respondents from all the major regions we are working on.

Some Facts About The Brainy Insights

50%

Free Customization

300+

Fortune 500 Clients

1

Free Yearly Update On Purchase Of Multi/Corporate License

900+

Companies Served Till Date